Enterprise Innovation Institute

Top pharmaceutical company evaluates Optimer for precision liver medicine

Posted on: May 1, 2024

Aptamer Group has announced that its Optimer binder against cells associated with fibrotic liver disease, developed for targeted delivery of therapeutic payloads to fibrotic liver disease, has been sent to a ‘top 15’ pharma company for evaluation.

Read full post: Read More